0

531762

UNJHAFOR

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

UNJHA FORMULATIONS LTD. Share Price Today

Investment Returns

Over 1 Month -9.30% Over 3 Months -7.14% Over 6 Months -20.24% Over 1 Year -15.54%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

UNJHA FORMULATIONS LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 8.40
  • P/E Ratio (TTM) 12.42
  • Beta 0.50
  • Book Value / share 8.57
  • Return on equity 8.77%
  • EPS (TTM) 1.57
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -0.74
info icon alternate text

UNJHA FORMULATIONS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 3.28
Operating Expense 3.82
Net Profit -0.74
Net Profit Margin (%) -22.56
Earnings Per Share (EPS) -1.66
EBITDA -0.45
Effective Tax Rate (%) -51.02
Particulars DEC 2025 (Values in Cr)
Revenue 4.41
Operating Expense 4.20
Net Profit 0.24
Net Profit Margin (%) 5.44
Earnings Per Share (EPS) 0.53
EBITDA 0.27
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 4.29
Operating Expense 3.53
Net Profit 0.82
Net Profit Margin (%) 19.11
Earnings Per Share (EPS) 1.83
EBITDA 0.85
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 3.61
Operating Expense 3.24
Net Profit 0.39
Net Profit Margin (%) 10.80
Earnings Per Share (EPS) 0.90
EBITDA 0.42
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 2.37
Operating Expense 2.73
Net Profit -0.41
Net Profit Margin (%) -17.29
Earnings Per Share (EPS) -0.91
EBITDA -0.26
Effective Tax Rate (%) -41.37
Particulars MAR 2026 (Values in Cr)
Revenue 15.59
Operating Expense 14.79
Net Profit 0.70
Net Profit Margin (%) 4.49
Earnings Per Share (EPS) 1.57
EBITDA 1.10
Effective Tax Rate (%) 26.31
Particulars MAR 2025 (Values in Cr)
Revenue 13.86
Operating Expense 13.45
Net Profit 0.41
Net Profit Margin (%) 2.95
Earnings Per Share (EPS) 0.91
EBITDA 0.63
Effective Tax Rate (%) 23.07
Particulars MAR 2024 (Values in Cr)
Revenue 18.50
Operating Expense 18.06
Net Profit 0.28
Net Profit Margin (%) 1.51
Earnings Per Share (EPS) 0.62
EBITDA 0.59
Effective Tax Rate (%) 37.77
Particulars MAR 2023 (Values in Cr)
Revenue 13.15
Operating Expense 12.86
Net Profit 0.28
Net Profit Margin (%) 2.12
Earnings Per Share (EPS) 0.63
EBITDA 0.47
Effective Tax Rate (%) 15.15
Particulars MAR 2022 (Values in Cr)
Revenue 14.16
Operating Expense 14.05
Net Profit 0.25
Net Profit Margin (%) 1.76
Earnings Per Share (EPS) 0.56
EBITDA 0.51
Effective Tax Rate (%) 16.66
Particulars MAR 2025 (Values in Cr)
Book Value / Share 7.01
ROE % 8.77
ROCE % 11.55
Total Debt to Total Equity 0.00
EBITDA Margin 4.55
Particulars MAR 2024 (Values in Cr)
Book Value / Share 6.10
ROE % 6.00
ROCE % 10.71
Total Debt to Total Equity 0.00
EBITDA Margin 3.14
Particulars MAR 2023 (Values in Cr)
Book Value / Share 5.48
ROE % 6.00
ROCE % 8.35
Total Debt to Total Equity 0.00
EBITDA Margin 3.57
Particulars MAR 2022 (Values in Cr)
Book Value / Share 4.84
ROE % 5.35
ROCE % 9.20
Total Debt to Total Equity 0.00
EBITDA Margin 3.60
Particulars MAR 2021 (Values in Cr)
Book Value / Share 4.28
ROE % 2.14
ROCE % 5.78
Total Debt to Total Equity 0.00
EBITDA Margin 3.51
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.64
Total Assets 4.55
Total Liabilities 4.55
Total Equity 3.13
Share Outstanding 0
Price to Book Ratio 3.11
Return on Assets (%) 8.94
Return on Capital (%) 12.98
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.87
Total Assets 4.93
Total Liabilities 4.93
Total Equity 2.73
Share Outstanding 0
Price to Book Ratio 3.10
Return on Assets (%) 5.63
Return on Capital (%) 10.18
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 3.40
Total Liabilities 3.40
Total Equity 2.45
Share Outstanding 0
Price to Book Ratio 2.28
Return on Assets (%) 8.28
Return on Capital (%) 11.52
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.42
Total Assets 3.45
Total Liabilities 3.45
Total Equity 2.17
Share Outstanding 0
Price to Book Ratio 1.94
Return on Assets (%) 7.30
Return on Capital (%) 11.63
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.17
Total Assets 3.52
Total Liabilities 3.52
Total Equity 1.91
Share Outstanding 0
Price to Book Ratio 1.99
Return on Assets (%) 2.93
Return on Capital (%) 5.4
Particulars MAR 2025 (Values in Cr)
Net Income 0.52
Cash from Operations 0.09
Cash from Investing -0.17
Cash from Financing 0.00
Net change in Cash -0.23
Free Cash Flow 0.28
Particulars MAR 2024 (Values in Cr)
Net Income 0.45
Cash from Operations 1.07
Cash from Investing -0.10
Cash from Financing -0.05
Net change in Cash 0.86
Free Cash Flow 1.18
Particulars MAR 2023 (Values in Cr)
Net Income 0.32
Cash from Operations -0.21
Cash from Investing -0.09
Cash from Financing -0.05
Net change in Cash -0.41
Free Cash Flow -0.10
Particulars MAR 2022 (Values in Cr)
Net Income 0.25
Cash from Operations 0.40
Cash from Investing -0.02
Cash from Financing 0.00
Net change in Cash 0.25
Free Cash Flow 0.43
Particulars MAR 2021 (Values in Cr)
Net Income 0.10
Cash from Operations -0.53
Cash from Investing -0.06
Cash from Financing 0.00
Net change in Cash -0.76
Free Cash Flow -0.46
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.29 14.58 1.70 270.44 23.12 38.50
BLISS GVS PHARMA LTD. 402.00 32.52 3.56 4252.72 118.35 437.40
CIPLA LTD. 1390.85 27.54 3.26 112352.94 1165.55 1672.20
FERMENTA BIOTECH LIMITED 300.35 13.25 2.17 883.96 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2203.65 36.57 16.46 37331.16 2184.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.29 24.68 4.54 270.44 23.12 38.50
AMRUTANJAN HEALTH CARE LTD. 558.20 25.02 4.35 1613.79 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8724.25 113.94 24.98 21810.63 7630.00 10653.05
BLISS GVS PHARMA LTD. 402.00 43.23 3.68 4252.72 118.35 437.40

UNJHA FORMULATIONS LTD. shareholding pattern

Holding
63.07%
36.92%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

UNJHA FORMULATIONS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
18.70 -4.10 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 19.50
  • 26 Days 20.00
  • 10 Days 19.60
  • 50 Days 20.40
  • 12 Days 19.60
  • 100 Days 21.30
  • 20 Days 19.80
  • 200 Days 22.50
19.50 PIVOT
First Support 19.50 First Resistance 19.50 Second Support 19.50 Second Resistance 19.50 Third Support 19.50 Third Resistance 19.50
RSI 45.64 ADX 49.05 MACD -0.35 Williams % R -71.94 Commodity Channel Index (CCI) -54.35
Date 2026-06-01 Week 770.00 Same Day 105.00 Month 765.00
1 Year 0.50 3 Year 0.35
Over 1 Month
-9.30% down
Over 1 Year
-15.54% down
Over 3 Months
-7.14% down
Over 3 Years
15.82% down
Over 6 Months
-20.24% down
Over 5 Years
15.51% down

UNJHA FORMULATIONS LTD. Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Unjha Formulations Ltd?

Answer Field

Unjha Formulations Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 18.70 as on Jun 03 2026 03:15 PM.

What is the Market Cap of Unjha Formulations Ltd Share?

Answer Field

The market cap of Unjha Formulations Ltd for NSE ₹ 0.00 & for BSE ₹ 8.40 as on Jun 03 2026 03:15 PM.

What is the 52 Week High and Low of Unjha Formulations Ltd?

Answer Field

The 52 Week High and Low of Unjha Formulations Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 30.40 and ₹ 18.60.

What is 1 year return for Unjha Formulations Ltd?

Answer Field

The 1 year returns on the stock has been -15.54%.

What is the P/E Ratio of Unjha Formulations Ltd Share?

Answer Field

As on Jun 03 2026 03:15 PM the price-to-earnings (PE) ratio for Unjha Formulations Ltd share is 12.42.

What is the PB ratio of Unjha Formulations Ltd Share?

Answer Field

As on Jun 03 2026 03:15 PM, the price-to-book (PB) ratio for Unjha Formulations Ltd share is 8.57.

How to Buy Unjha Formulations Ltd Share?

Answer Field

You can trade in Unjha Formulations Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Unjha Formulations Ltd Share on Bajaj Broking App?

Answer Field

To buy Unjha Formulations Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Unjha Formulations Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|